Efficacy of Romiplostim in thrombocytopenic dogs
Author(s):
Sunil S Bhagannavar, Balaji N Ambore, Santosh B Swami, Vitthal S Dhaygude, Sameer N Jadhav, Ajit B Mali, Yogesh B Jadhav and Tejas C Shende
Abstract:
A research investigation was carried out at the Veterinary Clinical Complex of KNP College of Veterinary Science, Shirwal, to examine the Signalment and frequency of thrombocytopenia in canines. The study involved the analysis of 20 thrombocytopenic dogs, where a detailed history was obtained and thorough clinical examinations were conducted to gather the necessary data. Dogs with a medical history of symptoms such as nasal bleeding, petechial haemorrhages, hematemesis, melena, fever, enlarged lymph nodes, anaemia, and lethargy underwent screening for thrombocytopenia. The common general observations in thrombocytopenic dogs were anorexia, in appetence, fever, petechial haemorrhages and melena. Affected dogs had significantly decreased platelet count. Administration of the injection romiplostim resulted in an 80% success rate in rapid recovery of platelet count and absence of any adverse effects.
How to cite this article:
Sunil S Bhagannavar, Balaji N Ambore, Santosh B Swami, Vitthal S Dhaygude, Sameer N Jadhav, Ajit B Mali, Yogesh B Jadhav, Tejas C Shende. Efficacy of Romiplostim in thrombocytopenic dogs. Pharma Innovation 2023;12(6):3870-3873.